BDBM50124331 CHEMBL262056::N-{3-[2-Amino-3-cyano-6-(2-hydroxy-phenyl)-pyridin-4-yl]-phenyl}-2-piperidin-1-yl-acetamide
SMILES: Nc1nc(cc(-c2cccc(NC(=O)CN3CCCCC3)c2)c1C#N)-c1ccccc1O
InChI Key: InChIKey=QISTVOQRBVFVDC-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inhibitor of nuclear factor kappa-B kinase subunit beta (Homo sapiens (Human)) | BDBM50124331 (CHEMBL262056 | N-{3-[2-Amino-3-cyano-6-(2-hydroxy-...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Kyoto 619-0216 Curated by ChEMBL | Assay Description In vitro inhibitory concentration required against recombinant human IkB kinase beta (IKK-beta) | Bioorg Med Chem Lett 13: 913-8 (2003) BindingDB Entry DOI: 10.7270/Q2TM7BP1 | |||||||||||
More data for this Ligand-Target Pair |